DANIEL SCHROER: Open Payments
NPI 1194105775 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 16 payments from 7 companies in 2025. Trend: 2023 $490 · 2024 $581 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $116 |
| Lilly USA, LLC | 3 | $49 |
| Exact Sciences Corporation | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: VRAYLAR, Cologuard Collection Kit, AIRSUPRA, MOUNJARO, PREVNAR 20, Ozempic, AREXVY, Wegovy.
Industry payments across OH — which companies pay providers there.
